Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-02-28 | ||||||
REV |
Q3 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.070 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
GNPX | Genprex | 3.87 | 0.12 | 3.2% | 161.5M |
You can purchase shares of Genprex (NASDAQ: GNPX) through any online brokerage.
Other companies in Genprex’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Lumos Pharma (NASDAQ:LUMO) and Taiwan Liposome Co (NASDAQ:TLC).
The latest price target for Genprex (NASDAQ: GNPX) was reported by Maxim Group on 2018-09-14. The analyst firm set a price target for 5.00 expecting GNPX to rise to within 12 months (a possible 33.33% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Genprex (NASDAQ: GNPX) is $3.75 last updated Fri Jan 15 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Genprex.
There is no upcoming split for Genprex.